In the present study, we employed various types of inhibitors to establish that activation of the FZD/LRP receptor complex is required for the augmentation of TCF/β-catenin transcriptional activity observed in MMTV-CUX1 mammary tumor cells. Here, HNF4A is linked to breast cancer.